2018
Management of rocuronium neuromuscular block using a protocol for qualitative monitoring and reversal with neostigmine
Thilen SR, Ng IC, Cain KC, Treggiari MM, Bhananker SM. Management of rocuronium neuromuscular block using a protocol for qualitative monitoring and reversal with neostigmine. British Journal Of Anaesthesia 2018, 121: 367-377. PMID: 30032875, DOI: 10.1016/j.bja.2018.03.029.Peer-Reviewed Original ResearchConceptsPostoperative residual neuromuscular blockResidual neuromuscular blockNeuromuscular blockTracheal extubationNeostigmine reversalRocuronium neuromuscular blockIdeal body weightConfidence intervalsNeostigmine administrationRocuronium administrationSecondary endpointsAppropriate dosingAbdominal surgeryFemale sexDose reductionExtubationBody weightControl groupPatientsIncidenceSurgical requirementsSignificant differencesNeostigmineAdministrationSubjective monitoring
2004
Occupational asbestos exposure and the incidence of non-hodgkin lymphoma of the gastrointestinal tract: an ecologic study
Treggiari MM, Weiss NS. Occupational asbestos exposure and the incidence of non-hodgkin lymphoma of the gastrointestinal tract: an ecologic study. Annals Of Epidemiology 2004, 14: 168-171. PMID: 15036219, DOI: 10.1016/s1047-2797(03)00241-2.Peer-Reviewed Original ResearchConceptsOccupational asbestos exposureNon-Hodgkin lymphomaRates of mesotheliomaAsbestos exposureGastrointestinal tractNational Cancer Institute's SurveillanceEcologic studyPrevious case-control studyIncidence of malignancyEnd Results ProgramCase-control studyMen age 50Results ProgramOccupational exposureSubsequent incidenceAge 50IncidenceMesotheliomaStrong associationLymphomaTractExposureSurveillanceUS regionsSan Francisco
2002
Postmenopausal hormone use and skeletal fracture: does the size of the benefit decrease with increasing age?
Weiss NS, Treggiari MM. Postmenopausal hormone use and skeletal fracture: does the size of the benefit decrease with increasing age? Obstetrics And Gynecology 2002, 100: 364-8. PMID: 12151165, DOI: 10.1016/s0029-7844(02)02046-x.Peer-Reviewed Original ResearchConceptsLong-term hormone useOlder postmenopausal womenPostmenopausal womenHormone useFracture riskYounger postmenopausal womenPostmenopausal hormone useSurrogate end pointsBone mineral densityUse of hormonesHormone therapySkeletal benefitsRandomized trialsSuch therapyMineral densitySkeletal fracturesAbsolute reductionEnd pointStudy of hormonesWomenHealth careTrialsAgeTrue declineRisk